Category: Company News

Strong commercial momentum for BRINSUPRI and continued growth from ARIKAYCE prompted Insmed to raise its 2026 outlook and increase peak revenue expectations for its lead programmes. Key Investor Takeaways Why INSM Stock Is in Focus Insmed (NASDAQ:INSM) reported total second-quarter 2026 revenue of $425.5 million, driven by continued commercial strength from BRINSUPRI, which generated $309.2…

Record quarterly revenue, improving margins and continued commercial momentum are prompting Iovance to reassess its full-year guidance while advancing multiple late-stage clinical programmes. Key Investor Takeaways Why (NASDAQ:IOVA) Stock Is in Focus Iovance Biotherapeutics (NASDAQ:IOVA) delivered record second-quarter revenue of approximately $99.3 million, a 66% increase from the prior-year quarter and a 39% improvement over…

The healthcare company has introduced two new research-use PCR tests as demand for cyclospora detection grows during an ongoing U.S. outbreak. Key Investor Takeaways Why RHHBY Stock Is in Focus Roche (USOTC:RHHBY) announced the launch of two new real-time PCR assays designed to detect Cyclospora cayetanensis, the parasite responsible for cyclosporiasis, as laboratories seek additional…

The joint venture significantly expands SurgePays’ nationwide distribution network and supports its long-term goal of exceeding one million wireless subscribers. Key Investor Takeaways Why SURG Stock Is in Focus SurgePays (NASDAQ:SURG) announced the creation of Redline Wireless Group, a joint venture designed to accelerate the distribution of its prepaid wireless services across one of the…

The transaction adds a clinical-stage pain therapy with FDA Orphan Drug Designation while providing funding expected to support development through Phase 2 data and into registrational planning. Key Investor Takeaways Why ENSC Stock Is in Focus Ensysce Biosciences (NASDAQ:ENSC) has completed its acquisition of private biotechnology company Cy Biopharma, bringing clinical-stage drug candidate CY200 into…

The agreement could support the development of a domestic U.S. scandium supply chain, although the proposed supply arrangement remains non-binding and depends on future project development. Key Investor Takeaways Why NB Stock Is in Focus NioCorp Developments (NASDAQ:NB) announced a memorandum of understanding with Lockheed Martin covering the potential purchase of up to 15 tonnes…

The five-year partnership includes a broad patent cross-license, memory supply agreement, technology collaboration, settlement of ongoing litigation, and Samsung’s planned purchase of Netlist shares. Key Investor Takeaways Why NLST Stock Is in Focus Netlist (USOTC:NLST) announced a strategic alliance with Samsung after the companies signed five-year agreements covering patent cross-licensing, memory product supply, and technology…

New drilling continues to extend the Pepas West discovery, prompting Orosur to evaluate faster drilling methods to define a shallow oxide gold zone that could support future mine development. Key Investor Takeaways Why OROXF Stock Is in Focus Orosur Mining (USOTC:OROXF) announced assay results from six additional drill holes at the Pepas West prospect within…

Italy’s regulatory clearance removes the principal governmental hurdle for NUBURU’s planned acquisition of a 70% controlling stake in defense company Tekne, allowing the transaction to move toward closing. Key Investor Takeaways Why BURU Stock Is in Focus NUBURU (USOTC:BURU) announced that the Italian Government has approved its proposed acquisition of a 70% controlling interest in…

The smart energy technology company delivered its strongest profitability improvement in several quarters, driven by higher revenue, expanding margins, and continued progress in its turnaround strategy. Key Investor Takeaways Why SEDG Stock Is in Focus SolarEdge Technologies (NASDAQ:SEDG) reported second-quarter 2026 revenue of $346.2 million, an increase of 19.6% from a year earlier and 11.5%…